Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-007946

SVP & General Counsel sold 5,344 shares at $19.45 ($103,941)

  • SVP & General Counsel acquired 5,344 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2021-02-03 Option exercise −5,344 $8.80 $47,027 84,244 D: show line 1 in the form
Wilson Mark Andrew SVP & General Counsel 2021-02-03 Sale −5,344 $19.45 $103,941 78,900 D: show line 2 in the form
Open-market sales · 5,344 sh · avg $19.45 · $103,941

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2021-02-03 Option exercise · Stock Option −5,344 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…